On March 20, 2025, HHS and the Drug Enforcement Administration (DEA) released a notice that two final rules related to telemedicine scheduled to become effective on March 21, 2025, the “Expansion of Buprenorphine Treatment via Telemedicine Encounter” and “Continuity of Care via Telemedicine for Veterans Affairs Patients” final rules, would be delayed to December 31, 2025. During the comment perio
Membership Required
This content is restricted to ACOFP members.
Not a member? Join ACOFP to access this content, plus receive the wealth of benefits and community ACOFP membership offers.
If you need further assistance, please send us a message.